Evidence-Based Scar Treatments for the Upper Extremity

Upper Extremity Scar Treatment: Comprehensive Clinical Guide

Overview

Scars on the upper extremity can result from trauma, burns, surgery, or injury, potentially causing functional impairment, pain, pruritus, and aesthetic concerns. Effective scar management requires understanding the different scar types—hypertrophic scars, keloids, and atrophic scars—and implementing evidence-based treatment strategies tailored to each patient’s needs.

Types of Upper Extremity Scars

Hypertrophic Scars: Raised, thickened scars that remain within the boundaries of the original wound and may regress spontaneously over time.

Keloid Scars: Elevated scars that extend beyond the original wound margins and rarely regress without intervention. More common in individuals with darker skin types and those with genetic predisposition.

Atrophic Scars: Depressed scars resulting from loss of underlying tissue, commonly seen after trauma or certain skin conditions.

First-Line Conservative Treatments

Silicone Gel Sheeting and Silicone Gel

Silicone-based products represent the gold standard for scar prevention and treatment. These products work by hydrating the stratum corneum, regulating temperature, and modulating fibroblast-keratinocyte signaling.

Application Protocol:

– Begin 2 weeks post-injury or post-surgery

– Apply daily for 6 weeks minimum

– Wear 12-24 hours per day for optimal results

– Both silicone gel sheets and topical silicone gels show equal effectiveness

Benefits: Reduces scar thickness, erythema, and overall severity with minimal adverse effects.

Pressure Therapy

Pressure garments deliver 15-25 mm Hg of compression to reduce inflammatory cytokine release, decrease collagen synthesis, and improve scar pliability.

Indications:

– Burns and extensive scarring

– Hypertrophic scars on the forearm, hand, or arm

– Post-surgical scars in high-risk patients

Protocol: Wear 23 hours daily for up to 2 years or until scar maturation. Pressure therapy combined with silicone gel sheeting may provide additional benefits for scar height and pliability.

Intralesional Injection Therapies

Corticosteroid Injections (Triamcinolone Acetonide)

Triamcinolone injections (10-40 mg/mL) are accessible first-line therapy for keloids and hypertrophic scars, with 50-100% of patients experiencing scar regression after 3-6 months of monthly treatments.

Technique:

– Inject within lesion boundaries to avoid fat atrophy

– Monthly treatments for 3-6 months

– For post-surgical keloid prevention, administer 10-14 days post-surgery (superior to pre- or intraoperative injection)

Adverse Effects: Pain, skin atrophy, hypopigmentation, telangiectasia

Combination Therapy: Enhanced outcomes when combined with 5-fluorouracil, pulsed-dye laser, or cryotherapy.

5-Fluorouracil (5-FU)

5-FU injections (50 mg/mL) improve scar texture and erythema in 78% of patients as monotherapy and 96% when combined with corticosteroids.

OnabotulinumtoxinA (Botox)

Emerging evidence suggests onabotulinumtoxinA may be superior to fluorouracil and corticosteroid injections for treating keloids and hypertrophic scars, though this is an off-label use.

Cryotherapy

Intralesional liquid nitrogen cryotherapy offers effective scar regression with fewer treatment cycles compared to spray or contact methods. Treatment typically requires 2-3 week intervals.

Laser Therapy for Upper Extremity Scars

Laser therapy has become a cornerstone of advanced scar management, with different modalities targeting specific scar characteristics.

Ablative Lasers

Fractional CO2 Laser (10,600 nm):

– First-line treatment for hypertrophic scars

– Achieves >50% improvement in 37-65% of patients

– Higher efficacy but increased pain and downtime compared to non-ablative options

Erbium:YAG Laser (2,940 nm):

– Effective for both atrophic and hypertrophic scars

– 52-85% of patients report improvement

– Better cosmetic outcomes when treating hypertrophic and keloid scars

Non-Ablative Lasers

Pulsed-Dye Laser (PDL, 585-595 nm):

– Targets scar vascularity and erythema

– May improve hypertrophic and keloid scar severity compared to no treatment

– Response rates of 55% for keloids

Nd:YAG Laser (1,064 nm):

– Recovery rate of 65% for hypertrophic scars and keloids

– Enhanced results when combined with intralesional triamcinolone

Fractional Non-Ablative Lasers (1,550 nm Er:glass):

– Lower pain and downtime

– Comparable results to ablative lasers for hypertrophic scars

Combination Laser Therapy

Combining laser treatment with intralesional corticosteroids, 5-FU, or botulinum toxin enhances outcomes and reduces recurrence rates.

Surgical Intervention

When conservative therapies fail, surgical excision may be warranted, particularly for scars causing functional impairment over joints.

Key Principles:

– Use tension-reducing techniques (Z-plasty, W-plasty, wedge excision)

– Combine with adjuvant therapies to reduce recurrence

– Administer intralesional triamcinolone 10-14 days post-surgery

– Consider radiation therapy for keloids (reduces recurrence to ≤22%)

Recurrence Rates: Surgery alone: 45-100%; Surgery with adjuvant therapy: significantly reduced

Radiation Therapy

Radiation therapy effectively treats and prevents keloid recurrence, particularly when combined with surgical excision. Protocols typically involve 2-5 days of treatment with low cancer risk.

Efficacy:

– Monotherapy: 37% recurrence rate

– Combined with surgery: